The relationship between lifestyle behaviors and tension-type headache and migraine: A systematic review and meta-analysis
Abstract
Background: Despite the growing recognition of lifestyle factors as potential modifiable influencers of headache disorders, research on the association between lifestyle behaviors and migraine or tension-type headache (TTH) remains limited. Therefore, the objective of this study was to evaluate the potential association between lifestyle behaviors and these 2 headache disorders (migraine and TTH).
Methods: A comprehensive database search was conducted in PubMed, Embase, Cochrane Library, Scopus, and Web of Science up to May 2024 to identify observational studies. Relative risk (RR) values were extracted from the eligible studies, and pooled RRs were calculated through meta-analysis. Two independent investigators performed data screening to ensure the accuracy and reliability of the data.
Results: A total of 7 studies (32,197 participants) were included. The results showed no significant association between alcohol consumption and migraine (RR = 0.87, 95% confidence interval (CI): 0.47-1.62), body mass index (BMI) and migraine (RR = 1.13, 95% CI: 0.87-1.48), or smoking/physical activity/alcohol consumption and TTH (RR = 1.12, 95% CI: 0.96-1.30; RR = 0.91, 95% CI: 0.70-1.20; RR = 1.07, 95% CI: 0.78-1.45, respectively).
Conclusion: Consistent with these findings, the present study concludes that no significant association was observed between lifestyle behaviors (alcohol consumption, BMI, smoking, physical activity) and the risk of migraine or TTH. Further studies are warranted…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 32,197 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.